Farallon Capital Management’s Protara Therapeutics TARA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-425,000	Closed	-$7.15M	–	151
2020 Q3	$7.15M	Buy	+425,000	New	+$7.15M	0.05%	101